Pete Yonkman, president of Cook Group and Cook Medical, was among the speakers Monday at the official launch of the new ...

Eli Lilly (NYSE: LLY) sells a broad variety of drugs across ... This player's units include medical devices, diagnostics, ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

Industry watchers expect global biotech mergers and acquisition activity to strengthen in 2025 after a subdued 2024, aiding ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... ll have a lot of winners with these drug and medical device plays.” For this article, we compiled a list ...

Obstructive sleep apnea is usually treated using positive airway pressure via a medical device, but not all patients are able to use PAP machines. The opportunity for Eli Lilly is significant ...

Eli Lilly has expanded a collaboration with ... against rivals such as Apple and FitBit whose wearable devices have an increasing medical focus with tech like ECG readers. ActiGraph provides ...

ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage ... Minnesota settlement; joins Lilly, Sanofi January 27, 2025 ...

The five devices covered by the new guidance include two that are strapped to the wrist with sensors attached to the finger and chest – the WatchPat 300 and WatchPat ONE from Itamar Medical ...

Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular ...